Skip to main content
Clinical Trials/NCT03189277
NCT03189277
Unknown
Not Applicable

Clinical Characteristics, Evaluation and Management of Lung Cancer Related-pain in Northern China: a Hospital-based Cross-sectional Study

Chinese Academy of Medical Sciences0 sites2,000 target enrollmentJune 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer Pain
Sponsor
Chinese Academy of Medical Sciences
Enrollment
2000
Primary Endpoint
Prevalence of cancer-related pain in lung cancer patients in 20 hospitals in northern China
Last Updated
8 years ago

Overview

Brief Summary

This cross-sectional study, utilizing two sets of questionaire designed for patients and physicians respectively, aims at the epidemiology, the clinical features, and the current status of evaluation and management of lung cancer related pain in 20 participating hospitals in Northern China.

Detailed Description

Lung malignancies have become the most common cause of mortality among patients with cancer in China. A significant proportion of lung cancer patients suffer from cancer related pain, however few studies have reported the prevalence and clinical features of such pain, especially in China. This study is a cross-sectional survey in 20 hospitals in Northern China. We designed two separate series of questions to be answered by patients and cancer management professionals. In the patient questionaire, we collect information on the prevalence, location, intensity, impact on life of lung cancer related pain. Questions on how doctors evaluate and manage the pain are included in both the patients' and physicians' surveys. In the doctors' questionaire, we also assess current situation of cancer pain educational programs attended in medical schools and post graduation through related questions.

Registry
clinicaltrials.gov
Start Date
June 2017
End Date
September 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shi Yuankai

Vice president of National Cancer Center Chinese Academy of Medical Sciences

Chinese Academy of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • The patient questionaire
  • All patients (outpatient and inpatient) diagnosed with lung cancer visiting the participating hospitals on the designated day of investigation
  • Informed consent must be obtained from the participating patients
  • The physician questionaire
  • All physicians who receive lung cancer patients (outpatient and inpatient) in the participating hospitals on the designated day of investigation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Prevalence of cancer-related pain in lung cancer patients in 20 hospitals in northern China

Time Frame: 24 hours

the proportion of self-reported pain related to cancer affecting the enrolled lung cancer patients over the past 24 hours

Similar Trials